Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

ENGLISH EDITION

CASMN Leads the Working Group for the Dissolving Microcrystal Patch Group Standard (Translation)

CASMN was appointed leader of the working group responsible for drafting the Chinese group standard for dissolving microcrystal patches.

Read the original Chinese article: 荣膺《可溶性微晶贴》团体标准编写工作组组长单位 →
CASMN Leads the Working Group for the Dissolving Microcrystal Patch Group Standard

In May 2023, CASMN was appointed leader of the working group drafting the group standard for dissolving microcrystal patches by the group-standards office of the China Anti-Aging Promotion Association. The announcement was published on 26 June 2023.

A framework for product development

The standard concerns research and development of microcrystal products. The original announcement prints an incomplete standard identifier; the exact designation and edition should be checked against the published standard before it is cited in technical documentation.

Company background at the time of the announcement

Founded in 2018, CASMN described a technology portfolio spanning three principal categories and six microneedle approaches, including layered dissolving, sustained-release and swelling structures.

The 2023 report listed more than 50 patents across technology, formulation, processing, equipment and packaging, a 4,025-square-metre Beijing R&D centre and an 8,100-square-metre Chongqing production base. These are historical figures from the announcement and should not be substituted for current facility or patent records.

Participation in a group-standard working group is distinct from certification or regulatory approval of an individual product.